Force	force	O	O	O	O
overflow	overflow	O	O	O	O
and	and	O	O	O	O
levodopa-induced	levodopa-induced	O	O	O	O
dyskinesias	dyskinesias	O	DISEASE	OTHERS	I
in	in	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
assessed	assessed	O	O	O	O
force	force	O	O	O	O
coordination	coordination	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
hand	hand	O	O	O	O
in	in	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
and	and	O	O	O	O
its	its	O	O	O	O
relationship	relationship	O	O	O	O
to	to	O	O	O	O
motor	motor	O	O	O	O
complications	complications	O	O	O	O
of	of	O	O	O	O
levodopa	levodopa	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
,	,	O	O	O	O
particularly	particularly	O	O	O	O
to	to	O	O	O	O
levodopa-induced	levodopa-induced	O	O	O	O
dyskinesias	dyskinesias	O	DISEASE	OTHERS	I
(	(	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
studied	studied	O	O	O	O
two	two	O	O	O	O
groups	groups	O	O	O	O
of	of	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
with	with	O	O	O	O
(	(	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
+	+	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
,	,	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
23	23	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
without	without	O	O	O	O
levodopa-induced	levodopa-induced	O	O	O	O
dyskinesias	dyskinesias	O	DISEASE	OTHERS	I
(	(	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
-	-	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
,	,	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
10	10	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
age-matched	age-matched	O	O	O	O
healthy	healthy	O	O	O	O
controls	controls	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
motor	motor	O	O	O	O
score	score	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
Unified	unified	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
Disease	disease	O	DISEASE	OTHERS	I
Rating	rating	O	O	O	O
Scale	scale	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
dyskinesia	dyskinesia	O	DISEASE	OTHERS	I
score	score	O	O	O	O
and	and	O	O	O	O
force	force	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
grip-lift	grip-lift	O	O	O	O
paradigm	paradigm	O	O	O	O
were	were	O	O	O	O
assessed	assessed	O	O	O	O
ON	on	O	O	O	O
and	and	O	O	O	O
OFF	off	O	O	O	O
levodopa	levodopa	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
pathological	pathological	O	O	O	O
increase	increase	O	O	O	O
of	of	O	O	O	O
forces	forces	O	O	O	O
was	was	O	O	O	O
seen	seen	O	O	O	O
in	in	O	O	O	O
ON-state	on-state	O	O	O	O
in	in	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
+	+	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
only	only	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
+	+	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
force	force	O	O	O	O
involved	involved	O	O	O	O
in	in	O	O	O	O
pressing	pressing	O	O	O	O
down	down	O	O	O	O
the	the	O	O	O	O
object	object	O	O	O	O
before	before	O	O	O	O
lifting	lifting	O	O	O	O
was	was	O	O	O	O
significantly	significantly	O	O	O	O
increased	increased	O	O	O	O
by	by	O	O	O	O
levodopa	levodopa	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
by	by	O	O	O	O
61	61	O	O	O	O
%	%	O	O	O	O
,	,	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

An	an	O	O	O	O
overshooting	overshooting	O	O	O	O
of	of	O	O	O	O
peak	peak	O	O	O	O
grip	grip	O	O	O	O
force	force	O	O	O	O
by	by	O	O	O	O
51	51	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
of	of	O	O	O	O
static	static	O	O	O	O
grip	grip	O	O	O	O
force	force	O	O	O	O
by	by	O	O	O	O
45	45	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.01	0.01	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
ON-	on-	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
OFF-drug	off-drug	O	O	O	O
condition	condition	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
,	,	O	O	O	O
no	no	O	O	O	O
excessive	excessive	O	O	O	O
force	force	O	O	O	O
was	was	O	O	O	O
found	found	O	O	O	O
in	in	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
-	-	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Peak	peak	O	O	O	O
grip	grip	O	O	O	O
force	force	O	O	O	O
in	in	O	O	O	O
ON-state	on-state	O	O	O	O
was	was	O	O	O	O
140	140	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.05	0.05	O	O	O	O
)	)	O	O	O	O
higher	higher	O	O	O	O
in	in	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
+	+	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
than	than	O	O	O	O
in	in	O	O	O	O
Parkinson	parkinson	O	DISEASE	OTHERS	I
's	's	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
-	-	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
,	,	O	O	O	O
while	while	O	O	O	O
static	static	O	O	O	O
grip	grip	O	O	O	O
force	force	O	O	O	O
was	was	O	O	O	O
increased	increased	O	O	O	O
by	by	O	O	O	O
138	138	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.01	0.01	O	O	O	O
)	)	O	O	O	O
between	between	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

Severity	severity	O	O	O	O
of	of	O	O	O	O
peak-dose	peak-dose	O	O	O	O
dyskinesias	dyskinesias	O	DISEASE	OTHERS	I
was	was	O	O	O	O
strongly	strongly	O	O	O	O
correlated	correlated	O	O	O	O
with	with	O	O	O	O
grip	grip	O	O	O	O
force	force	O	O	O	O
in	in	O	O	O	O
ON-state	on-state	O	O	O	O
(	(	O	O	O	O
r	r	O	O	O	O
=	=	O	O	O	O
0.79	0.79	O	O	O	O
with	with	O	O	O	O
peak	peak	O	O	O	O
force	force	O	O	O	O
,	,	O	O	O	O
P	p	O	O	OTHERS	I
<	<	O	O	O	O
0.01	0.01	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

No	no	O	O	O	O
correlation	correlation	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
between	between	O	O	O	O
forces	forces	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
motor	motor	O	O	O	O
score	score	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
daily	daily	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
dopaminergic	dopaminergic	O	O	O	O
medication	medication	O	O	O	O
.	.	O	O	O	O

Force	force	O	O	O	O
excess	excess	O	O	O	O
was	was	O	O	O	O
only	only	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
and	and	O	O	O	O
motor	motor	O	O	O	O
fluctuations	fluctuations	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
close	close	O	O	O	O
relationship	relationship	O	O	O	O
was	was	O	O	O	O
seen	seen	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
overshooting	overshooting	O	O	O	O
of	of	O	O	O	O
forces	forces	O	O	O	O
and	and	O	O	O	O
dyskinesias	dyskinesias	O	DISEASE	OTHERS	I
in	in	O	O	O	O
the	the	O	O	O	O
ON-drug	on-drug	O	O	O	O
condition	condition	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
postulate	postulate	O	O	O	O
that	that	O	O	O	O
both	both	O	O	O	O
LID	lid	O	DISEASE	OTHERS	I
and	and	O	O	O	O
grip	grip	O	O	O	O
force	force	O	O	O	O
excess	excess	O	O	O	O
share	share	O	O	O	O
common	common	O	O	O	O
pathophysiological	pathophysiological	O	O	O	O
mechanisms	mechanisms	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
motor	motor	O	O	O	O
fluctuations	fluctuations	O	O	O	O
.	.	O	O	O	O

